Company Description
Allergan Specialty Therapeutics, Inc. a development stage company, conducts research and development of potential human pharmaceutical products and commercializes such products through licensing. The company's research and development is focused on ...
More
Related Business Topics
Breaking News
Reuters - Nov. 20, 2009, 5:27 AM
Forbes.com - Oct. 29, 2009, 12:57 PM
Forbes.com - Oct. 27, 2009, 3:50 AM
Forbes.com - Oct. 22, 2009, 3:56 AM
Forbes.com - Oct. 21, 2009, 4:43 PM
Official Site - Allergan
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%. Learn More.
RESTASIS.com
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%. Learn More.
RESTASIS.com

